General Information of Drug Transporter (DT)
DT ID DTD0194 Transporter Info
Gene Name SLC25A32
Transporter Name Mitochondrial folate transporter/carrier
Gene ID
81034
UniProt ID
Q9H2D1
Post-Translational Modification of This DT
Overview of SLC25A32 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Acetylation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A32 [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

209

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC25A32 Lysine 209 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          7 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A32 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

7

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A32 Serine 7 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A32 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

9

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A32 Serine 9 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A32 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

11

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A32 Serine 11 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC25A32 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

12

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A32 Serine 12 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC25A32 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

15

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A32 Serine 15 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC25A32 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

31

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A32 Serine 31 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC25A32 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

158

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A32 Serine 158 has the potential to affect its expression or activity.

  Threonine

          6 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A32 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

2

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A32 Threonine 2 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A32 [2] , [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

16

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A32 Threonine 16 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A32 [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

134

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A32 Threonine 134 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC25A32 [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

138

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A32 Threonine 138 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC25A32 [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

144

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A32 Threonine 144 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC25A32 [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

146

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A32 Threonine 146 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A32 [7] , [8]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

163

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A32 Tyrosine 163 has the potential to affect its expression or activity.

Ubiquitination

  Leucine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A32 [7]

Role of PTM

Potential impacts

Modified Residue

Leucine

Modified Location

148

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A32 Leucine 148 has the potential to affect its expression or activity.

  Lysine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A32 [9]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

175

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A32 Lysine 175 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A32 [9]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

209

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A32 Lysine 209 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A32 [9]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

272

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A32 Lysine 272 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC25A32 [7] , [10]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

280

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A32 Lysine 280 has the potential to affect its expression or activity.
References
1 Lysine Acetylation and Succinylation in HeLa Cells and their Essential Roles in Response to UV-induced Stress. Sci Rep. 2016 Jul 25;6:30212.
2 Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
3 Radiosensitization of human leukemic HL-60 cells by ATR kinase inhibitor (VE-821): phosphoproteomic analysis. Int J Mol Sci. 2014 Jul 7;15(7):12007-26.
4 Phosphoproteomics study on the activated PKC-induced cell death. J Proteome Res. 2013 Oct 4;12(10):4280-301.
5 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
6 A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells. Mol Cell Proteomics. 2015 Jun;14(6):1599-615.
7 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
8 Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007 Dec 14;131(6):1190-203.
9 UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
10 Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.